3-METHYL-4-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)ISOXAZOLE, 95.0%, 1g

1-ethyl-4-piperidinecarboxylic acid hydrochloride, 95.0%, 5g

Ethyl 3-(1-methyl-2-(((4-(N-((pentyloxy)carbonyl)carbamimidoyl)phenyl)amino)methyl)-N-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamido)propanoate (Dabigatran Impurity), 97%, 50mg

(2-Bromothiazol-5-yl)(morpholino)methanone, 98%, 5g

N-(2-aminoethyl)-3-chlorobenzene-1-sulfonamide hydrochloride, 95.0%, 250mg

4-Ethyl-o-xylene>99.0%(GC)0.1mL

Methyl 2-amino-5-bromo-3-iodobenzoate, 95.0%, 10g

2-[[2-(Dimethylamino)ethyl]methylamino]ethanol>97.0%(GC)(T)25mL

3-Amino-4-hydroxypyridine>98.0%(GC)(T)5g

Alcyne-dATP, ≥95%, 500 µl, emballage plastique.

3-Iodoimidazo[1,2-a]pyridine, 95.0%, 100g

T-BOC-N-AMIDO-PEG5-AMINE, 97.0%, 10g

1,1-Dimethoxynonane, 97%, 5g